Association between Clozapine-Induced Weight Gain and Serotonin 5-HT2C Receptor Gene Polymorphism in Patients with Schizophrenia / 대한정신약물학회지
Korean Journal of Psychopharmacology
;
: 312-318, 2004.
Artículo
en Coreano
| WPRIM
| ID: wpr-183880
ABSTRACT
OBJECTIVE:
Weight gain is one of the troublesome adverse reaction to clozapine treatment. This problem can lead to poor adherence to treatment. Clozapine-induced weight gain may be associated with genetic predisposition. Recent studies have shown that a polymorphism of the promoter region of the serotonin 5-HT2C receptor gene is associated with antipsychotic-induced weight gain. This study is to investigate the association of clozapine-induced weight gain with -759C/T polymorphism of serotonin 5-HT2C receptor promoter gene in schizophrenic patients.METHODS:
Fifty three patients with schizophrenia were included in this study. The subjects were divided into two groups according to body weight change between the start and 10 weeks of clozapine. The cutoff level of weight change is 5% increase of initial body weight. Genotypes of -759C/T polymorphism were identified from AciI-digested fragments of two-primer products amplified by polymerase chain reaction corresponding to -885 to -634 of the serotonin 5-HT2C receptor gene promoter region on chromosome X.RESULTS:
There were no differences of baseline variables between patient groups with and without weight gain. 4 of 32 male patients and 6 of 21 female patients had -759T allele, respectively. The authors found that patients with -759T allele had tendency to show less weight gain than those without this allele.CONCLUSION:
These findings suggest that clozapine- induced weight gain may be associated with genetic predisposition in schizophrenic patients.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Esquizofrenia
/
Peso Corporal
/
Cambios en el Peso Corporal
/
Aumento de Peso
/
Serotonina
/
Reacción en Cadena de la Polimerasa
/
Regiones Promotoras Genéticas
/
Clozapina
/
Predisposición Genética a la Enfermedad
/
Receptor de Serotonina 5-HT2C
Tipo de estudio:
Estudio pronóstico
Límite:
Femenino
/
Humanos
/
Masculino
Idioma:
Coreano
Revista:
Korean Journal of Psychopharmacology
Año:
2004
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS